West Oak Capital’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

West Oak Capital’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100	Closed	-$2K	–	362
2020 Q4	$2K	Hold	100	–	–	﹤0.01%	291
2020 Q3	$2K	Hold	100	–	–	﹤0.01%	270
2020 Q2	$1K	Hold	100	–	–	﹤0.01%	305
2020 Q1	$2K	Hold	100	–	–	﹤0.01%	260
2019 Q4	$2K	Hold	100	–	–	﹤0.01%	270
2019 Q3	$1K	Hold	100	–	–	﹤0.01%	293
2019 Q2	$2K	Hold	100	–	–	﹤0.01%	303
2019 Q1	$2K	Hold	100	–	–	﹤0.01%	299
2018 Q4	$1.77K	Hold	100	–	–	﹤0.01%	312
2018 Q3	$1.81K	Hold	100	–	–	﹤0.01%	342
2018 Q2	$1.96K	Hold	100	–	–	﹤0.01%	307
2018 Q1	$1.75K	Buy	+100	New	+$1.83K	﹤0.01%	317

West Oak Capital's CBMG Position: Q1 2021 in Review

West Oak Capital sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 100 shares — an estimated $2K sold.

West Oak Capital first reported a position in CBMG in Q1 2018 and held it in 12 quarters. The position peaked at $2K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

West Oak Capital reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
West Oak Capital sold 100 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $2K.
West Oak Capital first reported a position in Cellular Biomedicine Group, Inc. in Q1 2018 and held it in 12 quarters.
West Oak Capital's Cellular Biomedicine Group, Inc. position peaked at $2K in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on West Oak Capital's 13F filing for Q1 2021, filed 13 Apr 2021.